Cite
HARVARD Citation
Jung, J. et al. (2019). HRAS‐driven cancer cells are vulnerable to TRPML1 inhibition. EMBO reports. p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jung, J. et al. (2019). HRAS‐driven cancer cells are vulnerable to TRPML1 inhibition. EMBO reports. p. n/a. [Online].